CClinicalTrials.gg
CompletedNCT03285958Updated Oct 4, 2021Results posted

Tracking Physical Activity for Chronic Pain Management Among Older Adults in Detroit

An interventional study of STEPS Intervention in Chronic Pain, sponsored by University of Michigan. Completed at 1 site in United States. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2021-10-04.

Sponsored by University of Michigan · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
57
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

Wearable, commercially-available physical activity monitors are being increasingly incorporated into chronic pain self-management interventions as a tool to help patients set goals and to tailor intervention content based on patient progress. Yet older adults from resource-challenged communities may face significant barriers to using these monitors and reporting activity data. Our pilot study will focus on wearable monitor use among older adults in Detroit with chronic musculoskeletal pain, testing the feasibility and validity of various technology-based strategies for reporting daily step count data. The study will also assess whether six weeks of monitor use is associated with improvements in functioning, relative to a control group.

02

Conditions studied

  • Chronic Pain

Browse trials for

03

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age > 60 years
  • Ambulatory with or without assistive device
  • Community living
  • Have a SMS-capable cell phone
  • Internet access (via smartphone, in-home or elsewhere);
  • Self-reported chronic musculoskeletal pain (pain in muscles or joints for > 3 months)
  • >4 (0-10 scale) average pain level over last week
  • >1 day/previous 30 when pain made it difficult to do usual activities
  • Ability to travel to study location in Detroit for a one-time session

Exclusion criteria

Exclusion criteria:

  • Serious acute illness or hospitalization in last month
  • Planned surgery in next month
  • Severe cognitive impairment
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
57 participants (actual)

Study arms

  • Experimental
    STEPS Intervention Group

    Participants will receive a wearable physical activity monitor and will be asked to report their daily step count in 3 different ways (2 weeks each of SMS text messages, Interactive Voice Response calls (IVR), automatic upload) during the 6-week study period.

    Behavioral: STEPS Intervention

  • No intervention
    STEPS Control Group

    Participants in this group will not receive a wearable physical activity monitor and will not be asked to report their step count.

Interventions

  • BehavioralSTEPS Intervention

    Participants in the STEPS (Seniors Tracking Exercise for Pain Self-management) intervention will receive a commercially-available, wearable physical activity monitor. They will be asked to wear this monitor during waking hours for 6 weeks, reporting their daily step count every evening. The way in which participants report steps will change every 2 weeks. For the first 4 weeks of the study, participants will report via Interactive Voice Response (IVR) calls for 2 weeks and SMS text messages for 2 weeks. For the final two week period, research staff will help participants to set up the monitor to automatically send daily step counts to STEPS project staff. This can be done through a smartphone, tablet, or computer.

05

What researchers measure

Primary outcomes

  1. Change in Pain Interference

    The Patient-Reported Outcomes Measurement Information System (PROMIS-29) Pain Interference 4-item subscale, where a higher score indicates more pain interference. Items ask how much pain in the last 7 days has interfered with daily activities such as household chores and social activities (1=not at all to 5=very much). Raw scores are converted to T-scores (normed such that a score of 50 is the population mean and 10 T-score points=1 standard deviation). The possible range is 42 to 76, with a higher score representing worse outcome.

    Time frame: Baseline, eight weeks

  2. Adherence to Step Count Reporting - SMS

    Proportion of days that step count was successfully provided/possible reporting days for SMS

    Time frame: Two weeks

  3. Adherence to Step Count Reporting - IVR

    Proportion of days that step count was successfully provided/possible reporting days for IVR.

    Time frame: two weeks

  4. Adherence to Step Count Reporting - Sync

    Proportion of days that step count was successfully provided/possible reporting days for syncing with app

    Time frame: two weeks

Secondary outcomes

  1. Change in Physical Functioning

    The Physical Functioning 4-item subscale of the Patient-Reported Outcomes Measurement Information System (PROMIS)-29 Adult Profile. Items ask how much difficulty participant has in doing daily activities such as household chores, using stairs, and walking 15 minutes (1=without any difficulty to 5=unable to do); raw total scale scores range from 4 (high functioning) to 20 (low functioning). When converted to T-scores (normed such that a score of 50 is the population mean and 10 T-score points=1 standard deviation), the possible range is 23 to 57, with a higher score representing worse outcome.

    Time frame: Baseline, eight weeks

  2. Change in Social Participation

    Ability to Participate in Social Roles and Activities, a 4-item subscale from PROMIS-20 rating the amount of trouble (1=not at all to 5=very much) in participating in social roles such as family activities, leisure activities, and work. Raw total scale scores range from 4 (high functioning) to 20 (low functioning). When converted to T-scores (normed such that a score of 50 is the population mean and 10 T-score points=1 standard deviation), the possible range is 29 to 64, with a higher score representing worse outcome.

    Time frame: Baseline, eight weeks

  3. Validity of Manually-reported Step Count Data - SMS

    Correlation of manually-reported SMS data with automatically uploaded data - percentage of days that counts are within 50 steps of each other

    Time frame: Two weeks

  4. Validity of Manually Reported Step Count Data - IVR

    Correlation of manually-reported SMS data with automatically uploaded data - percentage of days that counts are within 50 steps of each other

    Time frame: Two weeks

06

Results

Posted Oct 4, 2021

Participant flow

Participant flow — Overall Study
MilestoneSTEPS Intervention GroupSTEPS Control Group
Started3324
Completed2823
Not completed51
Withdrew: Lost to follow-up11
Withdrew: Withdrawal by subject10
Withdrew: Not able to attend required orientation30

Outcome measures

PrimaryChange in Pain Interference

The Patient-Reported Outcomes Measurement Information System (PROMIS-29) Pain Interference 4-item subscale, where a higher score indicates more pain interference. Items ask how much pain in the last 7 days has interfered with daily activities such as household chores and social activities (1=not at all to 5=very much). Raw scores are converted to T-scores (normed such that a score of 50 is the population mean and 10 T-score points=1 standard deviation). The possible range is 42 to 76, with a higher score representing worse outcome.

Time frame:
Baseline, eight weeks
Reported as:
Mean · score on a scale
Change in Pain Interference
score on a scaleSTEPS Intervention GroupSTEPS Control Group
Change in Pain Interference-0.85 ± 6.2-0.21 ± 6.6
PrimaryAdherence to Step Count Reporting - SMS

Proportion of days that step count was successfully provided/possible reporting days for SMS

Time frame:
Two weeks
Reported as:
Count of units · person-days
Adherence to Step Count Reporting - SMS
person-daysSTEPS Intervention Group
Adherence to Step Count Reporting - SMS299
PrimaryAdherence to Step Count Reporting - IVR

Proportion of days that step count was successfully provided/possible reporting days for IVR.

Time frame:
two weeks
Reported as:
Count of units · person-days
Adherence to Step Count Reporting - IVR
person-daysSTEPS Intervention Group
Adherence to Step Count Reporting - IVR257
PrimaryAdherence to Step Count Reporting - Sync

Proportion of days that step count was successfully provided/possible reporting days for syncing with app

Time frame:
two weeks
Reported as:
Count of units · person-days
Adherence to Step Count Reporting - Sync
person-daysSTEPS Intervention Group
Adherence to Step Count Reporting - Sync267
SecondaryChange in Physical Functioning

The Physical Functioning 4-item subscale of the Patient-Reported Outcomes Measurement Information System (PROMIS)-29 Adult Profile. Items ask how much difficulty participant has in doing daily activities such as household chores, using stairs, and walking 15 minutes (1=without any difficulty to 5=unable to do); raw total scale scores range from 4 (high functioning) to 20 (low functioning). When converted to T-scores (normed such that a score of 50 is the population mean and 10 T-score points=1 standard deviation), the possible range is 23 to 57, with a higher score representing worse outcome.

Time frame:
Baseline, eight weeks
Reported as:
Mean · units on a scale (T-score)
Change in Physical Functioning
units on a scale (T-score)STEPS Intervention GroupSTEPS Control Group
Change in Physical Functioning-1.4 ± 3.5-0.85 ± 3.7
SecondaryChange in Social Participation

Ability to Participate in Social Roles and Activities, a 4-item subscale from PROMIS-20 rating the amount of trouble (1=not at all to 5=very much) in participating in social roles such as family activities, leisure activities, and work. Raw total scale scores range from 4 (high functioning) to 20 (low functioning). When converted to T-scores (normed such that a score of 50 is the population mean and 10 T-score points=1 standard deviation), the possible range is 29 to 64, with a higher score representing worse outcome.

Time frame:
Baseline, eight weeks
Reported as:
Mean · units on a scale
Change in Social Participation
units on a scaleSTEPS Intervention GroupSTEPS Control Group
Change in Social Participation0.28 ± 7.80.83 ± 8.4
SecondaryValidity of Manually-reported Step Count Data - SMS

Correlation of manually-reported SMS data with automatically uploaded data - percentage of days that counts are within 50 steps of each other

Time frame:
Two weeks
Reported as:
Count of units · person-days
Validity of Manually-reported Step Count Data - SMS
person-daysSTEPS Intervention Group
Validity of Manually-reported Step Count Data - SMS133
SecondaryValidity of Manually Reported Step Count Data - IVR

Correlation of manually-reported SMS data with automatically uploaded data - percentage of days that counts are within 50 steps of each other

Time frame:
Two weeks
Reported as:
Count of units · person-days
Validity of Manually Reported Step Count Data - IVR
person-daysSTEPS Intervention Group
Validity of Manually Reported Step Count Data - IVR94

Adverse events

Collected over 8 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
STEPS Intervention Group0/28 (0%)1/28 (3.6%)0/28 (0%)
STEPS Control Group0/23 (0%)0/23 (0%)0/23 (0%)
Most frequent serious events
Most frequent serious events
EventSTEPS Intervention GroupSTEPS Control Group
hospitalizationRespiratory, thoracic and mediastinal disorders1/280/23

Baseline characteristics

Note: This is the analytic sample (i.e., participants with baseline and 8-week follow-up data, representing 51 of 57 randomized.)

Age, Continuous
Age, Continuous(years)STEPS Intervention GroupSTEPS Control GroupTotal
Mean71.3 ± 7.169.3 ± 6.470.4 ± 6.8
Sex: Female, Male
Sex: Female, Male(Participants)STEPS Intervention GroupSTEPS Control GroupTotal
Female261945
Male246
Race (NIH/OMB)
Race (NIH/OMB)(Participants)STEPS Intervention GroupSTEPS Control GroupTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American272148
White000
More than one race112
Unknown or Not Reported011
Region of Enrollment
Region of Enrollment(participants)STEPS Intervention GroupSTEPS Control GroupTotal
United States282351
Pain intensity in last week
Pain intensity in last week(units on a scale)STEPS Intervention GroupSTEPS Control GroupTotal
Mean5.1 ± 1.35.4 ± 2.25.2 ± 1.8
PROMIS 4-item pain interference T-score
PROMIS 4-item pain interference T-score(units on a scale)STEPS Intervention GroupSTEPS Control GroupTotal
Mean58.7 ± 6.157.0 ± 8.458.0 ± 7.2
PROMIS 4-item physical function difficulty T-score
PROMIS 4-item physical function difficulty T-score(units on a scale)STEPS Intervention GroupSTEPS Control GroupTotal
Mean33.2 ± 4.331.9 ± 4.233.0 ± 5.2
PROMIS 4-item social partcipation T-score
PROMIS 4-item social partcipation T-score(units on a scale)STEPS Intervention GroupSTEPS Control GroupTotal
Mean38.1 ± 7.337.0 ± 6.437.6 ± 6.9
07

Study locations

1 site
  • University of Michigan
    Ann Arbor, Michigan 48109, United States
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Jun 19, 2018
  • Informed consent form · Jun 19, 2018

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Registry details

Key details

Study ID
NCT03285958
Lead sponsor
University of Michigan
Responsible party
Mary Janevic (Assistant Research Scientist, University of Michigan) — Principal investigator
First posted
Sep 18, 2017
Start date
Nov 16, 2017
Primary completion
Jul 20, 2018
Completion
Aug 14, 2018
Results posted
Oct 4, 2021
Last update
Oct 4, 2021

Study contacts

Mary Janevic
principal investigator · University of Michigan School of Public Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion